Arizona State University researchers claim microbiota transfer therapy reduces symptoms associated with autism and gastrointestinal problems for two years post-treatment. The study suggests MTT may be a promising option for helping to treat children with ASD who also have GI problems. The researchers stress further research, including double-blind, placebo-controlled randomized trials with a larger cohort be carried out.
A new study reveals smokers have lower levels of Baceroids in their microbiome. In contrast, the levels of Bacteriods were the same level in vapers as in non-smokers. Decreased Bacteriod levels are associated with obesity and Chron's disease.